Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

GEBBIA, Nicolo'
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.354
EU - Europa 4.474
AS - Asia 1.447
AF - Africa 46
SA - Sud America 10
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
Totale 15.348
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.334
IT - Italia 1.041
FI - Finlandia 898
UA - Ucraina 812
CN - Cina 729
DE - Germania 550
SG - Singapore 506
IE - Irlanda 262
SE - Svezia 228
GB - Regno Unito 226
RU - Federazione Russa 143
FR - Francia 89
RO - Romania 62
IN - India 56
KR - Corea 49
BE - Belgio 48
CI - Costa d'Avorio 32
IR - Iran 26
NL - Olanda 21
PL - Polonia 21
ES - Italia 18
CA - Canada 17
GR - Grecia 15
TR - Turchia 14
CH - Svizzera 12
HK - Hong Kong 9
EU - Europa 8
JP - Giappone 8
CZ - Repubblica Ceca 7
EG - Egitto 7
AT - Austria 6
UZ - Uzbekistan 6
VN - Vietnam 6
AU - Australia 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
BR - Brasile 4
LB - Libano 4
MY - Malesia 4
NZ - Nuova Zelanda 4
ID - Indonesia 3
PE - Perù 3
PK - Pakistan 3
ZA - Sudafrica 3
BD - Bangladesh 2
BG - Bulgaria 2
CL - Cile 2
IL - Israele 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
LY - Libia 2
MX - Messico 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AR - Argentina 1
AZ - Azerbaigian 1
BY - Bielorussia 1
DK - Danimarca 1
HR - Croazia 1
HU - Ungheria 1
IQ - Iraq 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
SA - Arabia Saudita 1
Totale 15.348
Salva come PNG Salva come JPEG
Città #
Fairfield 1.243
Chandler 847
Ashburn 799
Woodbridge 720
Wilmington 611
Houston 553
Ann Arbor 539
Seattle 491
Jacksonville 422
Singapore 404
Cambridge 386
Dublin 256
Des Moines 230
Palermo 225
Medford 219
Nanjing 151
Princeton 145
Altamura 144
Lawrence 105
Tulsa 102
New York 97
Boardman 95
San Diego 80
Santa Clara 76
Dearborn 74
Beijing 64
Milan 56
Ludwigshafen am Rhein 52
Shenyang 49
Brussels 48
Nanchang 46
Jinan 45
Seongnam 45
Hebei 44
Helsinki 44
Changsha 41
San Mateo 39
Tianjin 37
Abidjan 32
Saint Petersburg 31
Jiaxing 30
Munich 30
London 29
Kumar 26
Guangzhou 24
Kitzingen 24
Los Angeles 22
Venice 21
Falls Church 20
Zhengzhou 20
Bremen 19
Columbus 18
Tehran 18
Ningbo 17
San Paolo di Civitate 17
Verona 17
Rome 16
Auburn Hills 15
Chicago 15
Berlin 13
Lanzhou 13
Phoenix 13
Washington 13
Izmir 12
Kilburn 12
Kraków 12
Hangzhou 11
Düsseldorf 10
Kunming 10
Moscow 10
Redwood City 10
Haikou 9
Pune 9
Taiyuan 9
Athens 8
Fuzhou 8
Norwalk 8
Edinburgh 7
Mazara del Vallo 7
Monza 7
Taizhou 7
Toronto 7
Central District 6
Dallas 6
Erice 6
Florence 6
Indiana 6
Shanghai 6
Durham 5
Frankfurt am Main 5
Madrid 5
Orange 5
Polska 5
Prague 5
Atlanta 4
Mountain View 4
Mumbai 4
Rho 4
Sacramento 4
San Francisco 4
Totale 10.400
Salva come PNG Salva come JPEG
Nome #
The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment 279
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily). 276
Aurora-A overexpression as an early marker of reflux-related columnar mucosa and Barrett's oesophagus. 222
Heterocyclic and Phenyl Double-Bond-Locked Combretastatin Analogues Possessing Potent Apoptosis-inducing activity in HL60 and in MDR Cell lines 207
The role of histamine in doxorubicin and teniposide-induced cardiotoxicity in dog and mouse 202
Stilbene-based anticancer agents: Resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanism. 201
Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features 195
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma 193
Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy 189
Pterostilbene and 3'-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells 188
Anti-endothelin drugs in solid tumors 180
EGFR genomic alterations in cancer: prognostic and predictive values 175
Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies. 174
Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients 173
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study. 172
Bisphosphonate-related osteonecrosis of the jaw (BRONJ): run dental management designs and issues in diagnosis. 171
Activin A circulating levels in patients with bone metastasis from breast or prostate cancer 170
Overexpression of cyclin D1 and interaction between p27(Kip1) and tumour thickness predict lymph node metastases occurrence in lower lip squamous cell carcinoma 169
BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses. 167
Studies on the apoptotic activity of natural and synthetic retinoids: discovery of a new class of synthetic terphenyls that potently support cell growth and inhibit apoptosis in neuronal and HL-60 cells 166
I tumori della mammella e/o dell’ovaio di tipo eredofamiliare: strategie di prevenzione nelle donne ad alto rischio 164
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma 163
A phase II study of oxaliplatin (O) and gemcitabine (G) first line chemotherapy in patients with advanced biliary tract cancers 159
Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer. 159
Havep53 gene mutations and protein expression a different biological significance in colorectal cancer? 158
Clinical presentation and treatment of gastrointestinal stromal tumors. 156
Emotional expression and coping style in female breast cancer. 154
BRAFV600E Mutation and p27kip1 Expression in Papillary Carcinomas of the Thyroid ≤1 cm and Their Paired Lymph Node Metastases 153
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. 152
A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer. 152
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers 150
Identification of a terphenyl derivative that blocks the cell cycle in the G0-G1 phase and induces differentiation in leukemia cells. 150
Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale 148
A case of guillain-barre syndrome in a patient with non small cell lung cancer treated with chemotherapy 148
Ductal lavage: a valid method of risk assessment and of early diagnosis in breast cancer. 147
Ductal lavage: a way of carefully tracing the breast-secreting duct 145
Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cells 143
Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers 142
miR-20b Modulates VEGF Expression by Targeting HIF-1a and STAT3 in MCF-7 Breast Cancer Cells 142
Cathepsin D expression levels in nongynecological solid tumors: Clinical and therapeutic implications 141
Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia 141
Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma 133
TP53 in gastric cancer: mutations in the l3 loop and LSH motif DNA-binding domains of TP53 predict poor outcome 132
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 131
ELF regimen in advanced gastrointestinal malignancies: An analysis of its clinical effectiveness and toxicity 129
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients. 128
A case of squamocellular uterine cervix carcinoma metastatic to the skin with enterocutaneous fistula. 127
Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis. 127
Antiproliferative Agents That Interfere with the Cell Cycle at the G(1)-->S Transition: Further Development and Characterization of a Small Library of Stilbene-Derived Compounds 126
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? 125
Carcinoma squamocellulare del pene localmente avanzato: associazione tra risposta clinica e modificazione dei livelli di ferritina sierica. 124
Primary extranodal non-Hodgkin lymphomas of the uterus and the breast: report of three cases 122
Triplet schedule of weekly 5-Fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: A dose-finding and phase II study 121
Detection and clinical relevance of free-circulating tumor DNA in blood of patients with colorectal cancer 118
A prospective evaluation of the activity of human granulocyte-colony stimulating factor on the prevention of chemotherapy-related neutropenia in patients with advanced carcinoma 112
Alexithymia and coping style in women going to visit in a breast cancer center. 110
Bortezomib: a new pro-apoptotic agent in cancer treatment. 109
MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone. 108
Effects of Propolis in cancer cells 106
Ductal Lavage: a valid method of risk assessment and of early diagnosis in breast cance 106
Effetti antileucemici di due stilbeni identificati in uve provenienti da vigneti affetti da peronospora e Botrytis cinerea 105
Deep vein thrombosis and pulmonary embolism can be treated at home in cancer patients 105
Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. 104
Management and treatment of triple-negative breast cancer patients from the NEMESI study: An Italian experience. 104
Haemopoietic effects of 7 alpha, 17 beta Dimethyltestosterone 104
Persistance of residual vein thrombosis after an episode of deep vein thrombosis of the lower limbs and the risk of new cancer and cardiovascular disease. 103
“Prevalence and treatment of cancer pain in Italian oncological wards centres: a cross-sectional survey” 103
Weekly levofolinic acid and 5-fluorouracil plus hydroxyurea in metastatic gastrointestinal adenocarcinomas 103
Differential expression levels of urokinase-type plasminogen activator and cathepsin D in locally advanced laryngeal squamous cell carcinoma: Clinical implications 103
PML down-regulation in soft tissue sarcomas 102
Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106). 100
Ondasetron versus granisetron in the prevention of chemotherapy‐induced nausea and vomiting. Results of a prospective randomized trial 100
A phase II study of capecitabine oxaliplatin chemotherapy in metastatic breast cancer patients pretreated with anthracyclines and taxanes 98
A phase II study of Oxaliplatin Capecitabine chemotherapy in metastatic breast cancer patients pretreated with anthracyclines and taxanes 97
Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer. 95
Emergenze metaboliche 94
Detection and clinical relevance of free-circulating tumor DNA in blood of patients with colorectal cancer. Proceeding of ICACT Fifteenth International Congress on Anticancer Treatment February 9th 12th 2004, Paris accepted for oral presentation 93
New potential circulating markers for the therapeutic monitoring of metastatic bone disease. 92
Studio di phase II: Docetaxel settimanale come seconda linea chemioterapia nel carcinoma prostatico avanzato. 91
Studio del pattern di distribuzione dell'Activina A nel siero di pazienti con metastasi ossee da carcinoma prostatico in trattamento con acido zoledronico 90
Managing cancer patients with acute venous thromboembolism: exploring safe alternatives to hospitalisation 89
Effects of zoledronic acid on proteinase plasma levels in patients with bone metastases. 88
Alexithymia and copyng style in women going to visit in a breast cancer center 88
Cathepsin D, B and L circulating levels as prognostic markers of malignant progression 88
PML down-regulation in soft tissue sarcomas. 88
ACTIVIN A CIRCULATING LEVELS IN PATIENTS WITH PRIMARY OSTEOPOROSIS OR BONE METASTASES FROM BREAST CANCER 87
Gists eredo familiari e pediatrici: aspetti biomolecolari e clinici. 87
DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study 86
“Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer:the IGCS-COL multicentre, randomised, phase III study” 81
“Effects of combretastatin analogues on leukemic cell lines and normal hemopoietic cells” 81
Clinical guidelines for the management of gastrointestinal stromal tumors 80
Cardiotossicità e Cardioprotezione. 80
Weekly Paclitaxel (T) and pegylated liposomal Doxorubicin (PLD) as first line treatment in metastatic breast cancer (MBC) patients.VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 79
Design, synthesis, and biological evaluation of novel aminobisphosphonates possessing an in vivo antitumor activity through a gammadelta-T lymphocytes-mediated activation mechanism. 79
Epirubicina (EPI ) e Docetaxel (DOC ) come chemioterapia primaria ( C P ) nel trattamento del carcinoma mammario localmente avanzato ( CMLA ). VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 78
Effects of Zoledronic Acid on Cathepsin K circulating levels in patients with bone metastasis. 78
Activin A circulating levels in patients with osteoporosis or bone metastasis from breast cancer 78
Il polimorfismo S128R dell’E-Selectina: analisi genotipica e caratterizzazione funzionale nell’interazione cellule tumorale-endotelio. 75
Lysosomal alterations in heart and liver of mice treated with doxorubicin 75
GRUPPO ONCOLOGICO ITALIA MERIDIONALE. NOVEL ASSOCIATION WITH GEMCITABINE AND DOCETAXEL AS SALVAGE CHEMOTHERAPY IN METASTATIC BREAST CANCER PREVIOUSLY TREATED WITH ANTHRACYCLINES: RESULT OF A NULTICENTER PHASE II STUDY 74
Totale 12.955
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.311
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.311
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.983 0 0 0 0 0 419 381 208 359 192 281 143
2020/20212.328 79 175 90 483 322 81 176 114 233 164 175 236
2021/20221.817 77 437 21 91 93 52 103 86 237 223 91 306
2022/20232.341 258 446 43 250 240 370 177 171 256 15 85 30
2023/20241.061 34 149 86 91 68 214 114 110 5 31 15 144
2024/2025872 52 169 181 285 105 80 0 0 0 0 0 0
Totale 15.806